First, we prepared the sarkosyl-insoluble fractions from the brains of patients neuropathologically diagnosed as Alzheimer’s disease, PiD, PSP and CBD, and investigated the biochemical and ultrastructural properties of tau aggregates contained in these fractions (Supplementary Table 1). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.